MAZE
Maze Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:50:42 AM EST
31.52USD+0.929%(+0.29)70,476
MAZE Financials
In Q3 FY 2026 (ended ), Maze Therapeutics, Inc. Common Stock (MAZE) reported revenue of $0, net income of −$47.97M, operating cash flow of −$32.84M, and assets of $511.56M (filed ).
Loading financial statements…